Hone Health reports that doctors are reconsidering hormone therapy for breast cancer survivors, suggesting safe options may exist despite previous guidelines.

Clinicians need to familiarize themselves with menopause genitourinary symptom management so they can address the pressing medical needs of millions of women.

Adding Kisqali (ribociclib) to a nonsteroidal aromatase inhibitor helped patients with hormone receptor–positive, HER2-negative early breast cancer live longer without their disease returning, ...

Ribociclib plus nonsteroidal aromatase inhibitor therapy reduces the risk for invasive disease recurrence by 28.5% compared with nonsteroidal aromatase inhibitor ...

Inluriyo is approved for ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer after prior endocrine therapy failure. The EMBER-3 trial showed Inluriyo reduced cancer progression or death ...

Results of a phase 2 trial suggest that ruxolitinib cream 1.5% may be an effective treatment option for adults with nonatopic chronic hand eczema.

Findings showed denosumab-kyqq demonstrated similar quality, safety, and efficacy to the reference product. Bosaya is approved to treat postmenopausal women with osteoporosis at high risk for fracture ...

Eli Lilly has won the second FDA approval for an oral selective estrogen receptor degrader (SERD). Like the first oral SERD, Lilly’s imlunestrant is only cleared to treat ER-positive, HER2-negative ...

Publix has released its limited-edition ice cream flavors for the holiday season. The seasonal treats are available in both half-gallon and pint-sized containers. Flavors include holiday classics like ...

A trans-Atlantic journey, three robots and some trade secrets all went into the reviving of the childhood favorite. A trans-Atlantic journey, three robots and some ...